Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 139 entries
Sorted by: Best Match Show Resources per page
Effect of dose and time of injection of prostaglandin F(2alpha) in cycling ewes.

Theriogenology

Hackett AJ, Robertson HA.
PMID: 16725503
Theriogenology. 1980 May;13(5):347-51. doi: 10.1016/0093-691x(80)90046-1.

A study was done to evaluate the efficacy of graded doses of prostaglandin F(2alpha) (PGF(2alpha)) to induce regression of the corpus luteum and hence estrus, in cycling ewes when given on various days of the estrous cycle. One hundred...

Cite
Hackett AJ, Robertson HA. Effect of dose and time of injection of prostaglandin F(2alpha) in cycling ewes. Theriogenology. 1980;13(5):347-51doi: 10.1016/0093-691x(80)90046-1.
Hackett, A. J., & Robertson, H. A. (1980). Effect of dose and time of injection of prostaglandin F(2alpha) in cycling ewes. Theriogenology, 13(5), 347-51. https://doi.org/10.1016/0093-691x(80)90046-1
Hackett, A J, and Robertson, H A. "Effect of dose and time of injection of prostaglandin F(2alpha) in cycling ewes." Theriogenology vol. 13,5 (1980): 347-51. doi: https://doi.org/10.1016/0093-691x(80)90046-1
Hackett AJ, Robertson HA. Effect of dose and time of injection of prostaglandin F(2alpha) in cycling ewes. Theriogenology. 1980 May;13(5):347-51. doi: 10.1016/0093-691x(80)90046-1. PMID: 16725503.
Copy Download .nbib Format: NLM
Antibody-Drug Conjugates in Bladder Cancer.

Bladder cancer (Amsterdam, Netherlands)

Vlachostergios PJ, Jakubowski CD, Niaz MJ, Lee A, Thomas C, Hackett AL, Patel P, Rashid N, Tagawa ST.
PMID: 30112436
Bladder Cancer. 2018 Jul 30;4(3):247-259. doi: 10.3233/BLC-180169.

Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against...

Cite
Vlachostergios PJ, Jakubowski CD, Niaz MJ, et al. Antibody-Drug Conjugates in Bladder Cancer. Bladder Cancer. 2018;4(3):247-259doi: 10.3233/BLC-180169.
Vlachostergios, P. J., Jakubowski, C. D., Niaz, M. J., Lee, A., Thomas, C., Hackett, A. L., Patel, P., Rashid, N., & Tagawa, S. T. (2018). Antibody-Drug Conjugates in Bladder Cancer. Bladder cancer (Amsterdam, Netherlands), 4(3), 247-259. https://doi.org/10.3233/BLC-180169
Vlachostergios, Panagiotis J, et al. "Antibody-Drug Conjugates in Bladder Cancer." Bladder cancer (Amsterdam, Netherlands) vol. 4,3 (2018): 247-259. doi: https://doi.org/10.3233/BLC-180169
Vlachostergios PJ, Jakubowski CD, Niaz MJ, Lee A, Thomas C, Hackett AL, Patel P, Rashid N, Tagawa ST. Antibody-Drug Conjugates in Bladder Cancer. Bladder Cancer. 2018 Jul 30;4(3):247-259. doi: 10.3233/BLC-180169. PMID: 30112436; PMCID: PMC6087439.
Copy Download .nbib Format: NLM
The influence of oxygen vacancy on the electronic and optical properties of ABO.

Physical chemistry chemical physics : PCCP

Jia T, Zeng Z, Zhang X, Ohodnicki P, Chorpening B, Hackett G, Lekse J, Duan Y.
PMID: 31502599
Phys Chem Chem Phys. 2019 Sep 18;21(36):20454-20462. doi: 10.1039/c9cp03883c.

ABO3-δ (A = La, Sr, B = Fe, Co) perovskites are useful in a wide range of applications, including their recent exploration for application in high-temperature optical oxygen sensing for energy conversion devices such as solid oxide fuel cells....

Cite
Jia T, Zeng Z, Zhang X, et al. The influence of oxygen vacancy on the electronic and optical properties of ABO. Phys Chem Chem Phys. 2019;21(36):20454-20462doi: 10.1039/c9cp03883c.
Jia, T., Zeng, Z., Zhang, X., Ohodnicki, P., Chorpening, B., Hackett, G., Lekse, J., & Duan, Y. (2019). The influence of oxygen vacancy on the electronic and optical properties of ABO. Physical chemistry chemical physics : PCCP, 21(36), 20454-20462. https://doi.org/10.1039/c9cp03883c
Jia, Ting, et al. "The influence of oxygen vacancy on the electronic and optical properties of ABO." Physical chemistry chemical physics : PCCP vol. 21,36 (2019): 20454-20462. doi: https://doi.org/10.1039/c9cp03883c
Jia T, Zeng Z, Zhang X, Ohodnicki P, Chorpening B, Hackett G, Lekse J, Duan Y. The influence of oxygen vacancy on the electronic and optical properties of ABO. Phys Chem Chem Phys. 2019 Sep 18;21(36):20454-20462. doi: 10.1039/c9cp03883c. PMID: 31502599.
Copy Download .nbib Format: NLM
Measurement of the Antineutrino Spectrum from ^{235}U Fission at HFIR with PROSPECT.

Physical review letters

Ashenfelter J, Balantekin AB, Band HR, Bass CD, Bergeron DE, Berish D, Bowden NS, Brodsky JP, Bryan CD, Cherwinka JJ, Classen T, Conant AJ, Cox AA, Davee D, Dean D, Deichert G, Diwan MV, Dolinski MJ, Erickson A, Febbraro M, Foust BT, Gaison JK, Galindo-Uribarri A, Gilbert CE, Gilje KE, Hackett BT, Hans S, Hansell AB, Heeger KM, Insler J, Jaffe DE, Ji X, Jones DC, Kyzylova O, Lane CE, Langford TJ, LaRosa J, Littlejohn BR, Lu X, Martinez Caicedo DA, Matta JT, McKeown RD, Mendenhall MP, Minock JM, Mueller PE, Mumm HP, Napolitano J, Neilson R, Nikkel JA, Norcini D, Nour S, Pushin DA, Qian X, Romero-Romero E, Rosero R, Sarenac D, Surukuchi PT, Telles AB, Tyra MA, Varner RL, Viren B, White C, Wilhelmi J, Wise T, Yeh M, Yen YR, Zhang A, Zhang C, Zhang X.
PMID: 31347897
Phys Rev Lett. 2019 Jun 28;122(25):251801. doi: 10.1103/PhysRevLett.122.251801.

This Letter reports the first measurement of the ^{235}U ν[over ¯]_{e} energy spectrum by PROSPECT, the Precision Reactor Oscillation and Spectrum experiment, operating 7.9 m from the 85  MW_{th} highly enriched uranium (HEU) High Flux Isotope Reactor. With a...

Cite
Ashenfelter J, Balantekin AB, Band HR, et al. Measurement of the Antineutrino Spectrum from ^{235}U Fission at HFIR with PROSPECT. Phys Rev Lett. 2019;122(25):251801doi: 10.1103/PhysRevLett.122.251801.
Ashenfelter, J., Balantekin, A. B., Band, H. R., Bass, C. D., Bergeron, D. E., Berish, D., Bowden, N. S., Brodsky, J. P., Bryan, C. D., Cherwinka, J. J., Classen, T., Conant, A. J., Cox, A. A., Davee, D., Dean, D., Deichert, G., Diwan, M. V., Dolinski, M. J., Erickson, A., Febbraro, M., Foust, B. T., Gaison, J. K., Galindo-Uribarri, A., Gilbert, C. E., Gilje, K. E., Hackett, B. T., Hans, S., Hansell, A. B., Heeger, K. M., Insler, J., Jaffe, D. E., Ji, X., Jones, D. C., Kyzylova, O., Lane, C. E., Langford, T. J., LaRosa, J., Littlejohn, B. R., Lu, X., Martinez Caicedo, D. A., Matta, J. T., McKeown, R. D., Mendenhall, M. P., Minock, J. M., Mueller, P. E., Mumm, H. P., Napolitano, J., Neilson, R., Nikkel, J. A., Norcini, D., Nour, S., Pushin, D. A., Qian, X., Romero-Romero, E., Rosero, R., Sarenac, D., Surukuchi, P. T., Telles, A. B., Tyra, M. A., Varner, R. L., Viren, B., White, C., Wilhelmi, J., Wise, T., Yeh, M., Yen, Y. R., Zhang, A., Zhang, C., Zhang, X. (2019). Measurement of the Antineutrino Spectrum from ^{235}U Fission at HFIR with PROSPECT. Physical review letters, 122(25), 251801. https://doi.org/10.1103/PhysRevLett.122.251801
Ashenfelter, J, et al. "Measurement of the Antineutrino Spectrum from ^{235}U Fission at HFIR with PROSPECT." Physical review letters vol. 122,25 (2019): 251801. doi: https://doi.org/10.1103/PhysRevLett.122.251801
Ashenfelter J, Balantekin AB, Band HR, Bass CD, Bergeron DE, Berish D, Bowden NS, Brodsky JP, Bryan CD, Cherwinka JJ, Classen T, Conant AJ, Cox AA, Davee D, Dean D, Deichert G, Diwan MV, Dolinski MJ, Erickson A, Febbraro M, Foust BT, Gaison JK, Galindo-Uribarri A, Gilbert CE, Gilje KE, Hackett BT, Hans S, Hansell AB, Heeger KM, Insler J, Jaffe DE, Ji X, Jones DC, Kyzylova O, Lane CE, Langford TJ, LaRosa J, Littlejohn BR, Lu X, Martinez Caicedo DA, Matta JT, McKeown RD, Mendenhall MP, Minock JM, Mueller PE, Mumm HP, Napolitano J, Neilson R, Nikkel JA, Norcini D, Nour S, Pushin DA, Qian X, Romero-Romero E, Rosero R, Sarenac D, Surukuchi PT, Telles AB, Tyra MA, Varner RL, Viren B, White C, Wilhelmi J, Wise T, Yeh M, Yen YR, Zhang A, Zhang C, Zhang X. Measurement of the Antineutrino Spectrum from ^{235}U Fission at HFIR with PROSPECT. Phys Rev Lett. 2019 Jun 28;122(25):251801. doi: 10.1103/PhysRevLett.122.251801. PMID: 31347897.
Copy Download .nbib Format: NLM
Genome sequencing in congenital cataracts improves diagnostic yield.

Human mutation

Ma A, Grigg JR, Flaherty M, Smith J, Minoche AE, Cowley MJ, Nash BM, Ho G, Gayagay T, Lai T, Farnsworth E, Hackett EL, Slater K, Wong K, Holman KJ, Jenkins G, Cheng A, Martin F, Brown NJ, Leighton SE, Amor DJ, Goel H, Dinger ME, Bennetts B, Jamieson RV.
PMID: 34101287
Hum Mutat. 2021 Sep;42(9):1173-1183. doi: 10.1002/humu.24240. Epub 2021 Jun 15.

Congenital cataracts are one of the major causes of childhood-onset blindness around the world. Genetic diagnosis provides benefits through avoidance of unnecessary tests, surveillance of extraocular features, and genetic family information. In this study, we demonstrate the value of...

Cite
Ma A, Grigg JR, Flaherty M, et al. Genome sequencing in congenital cataracts improves diagnostic yield. Hum Mutat. 2021;42(9):1173-1183doi: 10.1002/humu.24240.
Ma, A., Grigg, J. R., Flaherty, M., Smith, J., Minoche, A. E., Cowley, M. J., Nash, B. M., Ho, G., Gayagay, T., Lai, T., Farnsworth, E., Hackett, E. L., Slater, K., Wong, K., Holman, K. J., Jenkins, G., Cheng, A., Martin, F., Brown, N. J., Leighton, S. E., Amor, D. J., Goel, H., Dinger, M. E., Bennetts, B., & Jamieson, R. V. (2021). Genome sequencing in congenital cataracts improves diagnostic yield. Human mutation, 42(9), 1173-1183. https://doi.org/10.1002/humu.24240
Ma, Alan, et al. "Genome sequencing in congenital cataracts improves diagnostic yield." Human mutation vol. 42,9 (2021): 1173-1183. doi: https://doi.org/10.1002/humu.24240
Ma A, Grigg JR, Flaherty M, Smith J, Minoche AE, Cowley MJ, Nash BM, Ho G, Gayagay T, Lai T, Farnsworth E, Hackett EL, Slater K, Wong K, Holman KJ, Jenkins G, Cheng A, Martin F, Brown NJ, Leighton SE, Amor DJ, Goel H, Dinger ME, Bennetts B, Jamieson RV. Genome sequencing in congenital cataracts improves diagnostic yield. Hum Mutat. 2021 Sep;42(9):1173-1183. doi: 10.1002/humu.24240. Epub 2021 Jun 15. PMID: 34101287.
Copy Download .nbib Format: NLM
Flow Features of the Near Wake of the Australian Boobook Owl (.

Integrative organismal biology (Oxford, England)

Lawley J, Ben-Gida H, Krishnamoorthy K, Hackett EE, Kopp GA, Morgan G, Guglielmo CG, Gurka R.
PMID: 33793685
Integr Org Biol. 2019 Feb 19;1(1):obz001. doi: 10.1093/iob/obz001. eCollection 2019.

The mechanisms associated with the ability of owls to fly silently have been the subject of scientific interest for many decades and may be relevant to bio-inspired design to reduce noise of flapping and non-flapping flying devices. Here, we...

Cite
Lawley J, Ben-Gida H, Krishnamoorthy K, et al. Flow Features of the Near Wake of the Australian Boobook Owl (. Integr Org Biol. 2019;1(1):obz001doi: 10.1093/iob/obz001.
Lawley, J., Ben-Gida, H., Krishnamoorthy, K., Hackett, E. E., Kopp, G. A., Morgan, G., Guglielmo, C. G., & Gurka, R. (2019). Flow Features of the Near Wake of the Australian Boobook Owl (. Integrative organismal biology (Oxford, England), 1(1), obz001. https://doi.org/10.1093/iob/obz001
Lawley, Jonathan, et al. "Flow Features of the Near Wake of the Australian Boobook Owl (." Integrative organismal biology (Oxford, England) vol. 1,1 (2019): obz001. doi: https://doi.org/10.1093/iob/obz001
Lawley J, Ben-Gida H, Krishnamoorthy K, Hackett EE, Kopp GA, Morgan G, Guglielmo CG, Gurka R. Flow Features of the Near Wake of the Australian Boobook Owl (. Integr Org Biol. 2019 Feb 19;1(1):obz001. doi: 10.1093/iob/obz001. eCollection 2019. PMID: 33793685; PMCID: PMC7671144.
Copy Download .nbib Format: NLM
Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease.

Veterinary medicine and science

Pezzanite LM, Hackett ES, McCready E, Easley JT.
PMID: 34405566
Vet Med Sci. 2021 Nov;7(6):2209-2218. doi: 10.1002/vms3.607. Epub 2021 Aug 17.

BACKGROUND: Bilateral sinus disease is relatively uncommon in horses, accounting for 3%-4.5% of horses with sinonasal disease, but may require bilateral paranasal surgery for complete resolution. Complications and recurrence following bilateral sinusotomy have not been reported or compared to...

Cite
Pezzanite LM, Hackett ES, McCready E, et al. Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease. Vet Med Sci. 2021;7(6):2209-2218doi: 10.1002/vms3.607.
Pezzanite, L. M., Hackett, E. S., McCready, E., & Easley, J. T. (2021). Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease. Veterinary medicine and science, 7(6), 2209-2218. https://doi.org/10.1002/vms3.607
Pezzanite, Lynn M, et al. "Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease." Veterinary medicine and science vol. 7,6 (2021): 2209-2218. doi: https://doi.org/10.1002/vms3.607
Pezzanite LM, Hackett ES, McCready E, Easley JT. Outcomes following single, caudally based bilateral versus unilateral frontonasal sinusotomy for treatment of equine paranasal sinus disease. Vet Med Sci. 2021 Nov;7(6):2209-2218. doi: 10.1002/vms3.607. Epub 2021 Aug 17. PMID: 34405566; PMCID: PMC8604118.
Copy Download .nbib Format: NLM
Multifaceted control of mRNA translation machinery in cancer.

Cellular signalling

Alboushi L, Hackett AP, Naeli P, Bakhti M, Jafarnejad SM.
PMID: 33975011
Cell Signal. 2021 Aug;84:110037. doi: 10.1016/j.cellsig.2021.110037. Epub 2021 May 08.

The mRNA translation machinery is tightly regulated through several, at times overlapping, mechanisms that modulate its efficiency and accuracy. Due to their fast rate of growth and metabolism, cancer cells require an excessive amount of mRNA translation and protein...

Cite
Alboushi L, Hackett AP, Naeli P, et al. Multifaceted control of mRNA translation machinery in cancer. Cell Signal. 2021;84:110037doi: 10.1016/j.cellsig.2021.110037.
Alboushi, L., Hackett, A. P., Naeli, P., Bakhti, M., & Jafarnejad, S. M. (2021). Multifaceted control of mRNA translation machinery in cancer. Cellular signalling, 84110037. https://doi.org/10.1016/j.cellsig.2021.110037
Alboushi, Lilas, et al. "Multifaceted control of mRNA translation machinery in cancer." Cellular signalling vol. 84 (2021): 110037. doi: https://doi.org/10.1016/j.cellsig.2021.110037
Alboushi L, Hackett AP, Naeli P, Bakhti M, Jafarnejad SM. Multifaceted control of mRNA translation machinery in cancer. Cell Signal. 2021 Aug;84:110037. doi: 10.1016/j.cellsig.2021.110037. Epub 2021 May 08. PMID: 33975011.
Copy Download .nbib Format: NLM
Lung Function and Respiratory Muscle Adaptations of Endurance- and Strength-Trained Males.

Sports (Basel, Switzerland)

Hackett DA.
PMID: 33321800
Sports (Basel). 2020 Dec 10;8(12). doi: 10.3390/sports8120160.

Diverse exercise-induced adaptations following aerobic endurance compared to strength-training programs is well documented, however, there is paucity of research specifically focused on adaptations in the respiratory system. The aim of the study was to examine whether differences in lung...

Cite
Hackett DA. Lung Function and Respiratory Muscle Adaptations of Endurance- and Strength-Trained Males. Sports (Basel). 2020;8(12)doi: 10.3390/sports8120160.
Hackett, D. A. (2020). Lung Function and Respiratory Muscle Adaptations of Endurance- and Strength-Trained Males. Sports (Basel, Switzerland), 8(12), . https://doi.org/10.3390/sports8120160
Hackett, Daniel A. "Lung Function and Respiratory Muscle Adaptations of Endurance- and Strength-Trained Males." Sports (Basel, Switzerland) vol. 8,12 (2020). doi: https://doi.org/10.3390/sports8120160
Hackett DA. Lung Function and Respiratory Muscle Adaptations of Endurance- and Strength-Trained Males. Sports (Basel). 2020 Dec 10;8(12). doi: 10.3390/sports8120160. PMID: 33321800; PMCID: PMC7764033.
Copy Download .nbib Format: NLM
Associations between Perceptual Fatigue and Accuracy of Estimated Repetitions to Failure during Resistance Exercises.

Journal of functional morphology and kinesiology

Hackett DA, Selvanayagam VS, Halaki M, Cobley SP.
PMID: 33467371
J Funct Morphol Kinesiol. 2019 Aug 09;4(3). doi: 10.3390/jfmk4030056.

The ability to accurately identify proximity to momentary failure during a set of resistance exercise might be important to maximise training adaptations. This study examined the association between perceptual fatigue and the accuracy of the estimated repetitions to failure...

Cite
Hackett DA, Selvanayagam VS, Halaki M, et al. Associations between Perceptual Fatigue and Accuracy of Estimated Repetitions to Failure during Resistance Exercises. J Funct Morphol Kinesiol. 2019;4(3)doi: 10.3390/jfmk4030056.
Hackett, D. A., Selvanayagam, V. S., Halaki, M., & Cobley, S. P. (2019). Associations between Perceptual Fatigue and Accuracy of Estimated Repetitions to Failure during Resistance Exercises. Journal of functional morphology and kinesiology, 4(3), . https://doi.org/10.3390/jfmk4030056
Hackett, Daniel A, et al. "Associations between Perceptual Fatigue and Accuracy of Estimated Repetitions to Failure during Resistance Exercises." Journal of functional morphology and kinesiology vol. 4,3 (2019). doi: https://doi.org/10.3390/jfmk4030056
Hackett DA, Selvanayagam VS, Halaki M, Cobley SP. Associations between Perceptual Fatigue and Accuracy of Estimated Repetitions to Failure during Resistance Exercises. J Funct Morphol Kinesiol. 2019 Aug 09;4(3). doi: 10.3390/jfmk4030056. PMID: 33467371; PMCID: PMC7739315.
Copy Download .nbib Format: NLM
Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?.

The world journal of men's health

Hackett G.
PMID: 32378365
World J Mens Health. 2020 Jul;38(3):271-284. doi: 10.5534/wjmh.200027. Epub 2020 Mar 26.

Important health problems in men such as type 2 diabetes (T2DM), insulin resistance, erectile dysfunction, benign prostatic hyperplasia and depression have been shown to have to share common pathological processes, such as endothelial dysfunction and inflammation. This paper discusses...

Cite
Hackett G. Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?. World J Mens Health. 2020;38(3):271-284doi: 10.5534/wjmh.200027.
Hackett, G. (2020). Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?. The world journal of men's health, 38(3), 271-284. https://doi.org/10.5534/wjmh.200027
Hackett, Geoffrey. "Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?." The world journal of men's health vol. 38,3 (2020): 271-284. doi: https://doi.org/10.5534/wjmh.200027
Hackett G. Should All Men with Type 2 Diabetes Be Routinely Prescribed a Phosphodiesterase Type 5 Inhibitor?. World J Mens Health. 2020 Jul;38(3):271-284. doi: 10.5534/wjmh.200027. Epub 2020 Mar 26. PMID: 32378365; PMCID: PMC7308237.
Copy Download .nbib Format: NLM
New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency.

Toxins

Burgin D, Périer C, Hackett G, Elliott M, Kwan D, Hornby F, Mir I, Maignel J, Liu SM, Beard M.
PMID: 34941672
Toxins (Basel). 2021 Nov 24;13(12). doi: 10.3390/toxins13120834.

Botulinum neurotoxins (BoNTs) are notorious toxins and powerful agents and can be lethal, causing botulism, but they are also widely used as therapeutics, particularly to treat neuromuscular disorders. As of today, the commercial BoNT treatments available are from native...

Cite
Burgin D, Périer C, Hackett G, et al. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. Toxins (Basel). 2021;13(12)doi: 10.3390/toxins13120834.
Burgin, D., Périer, C., Hackett, G., Elliott, M., Kwan, D., Hornby, F., Mir, I., Maignel, J., Liu, S. M., & Beard, M. (2021). New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. Toxins, 13(12), . https://doi.org/10.3390/toxins13120834
Burgin, David, et al. "New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency." Toxins vol. 13,12 (2021). doi: https://doi.org/10.3390/toxins13120834
Burgin D, Périer C, Hackett G, Elliott M, Kwan D, Hornby F, Mir I, Maignel J, Liu SM, Beard M. New Modified Recombinant Botulinum Neurotoxin Type F with Enhanced Potency. Toxins (Basel). 2021 Nov 24;13(12). doi: 10.3390/toxins13120834. PMID: 34941672.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 139 entries